Mónica M. Bernardo November 27, 2025 Few new drugs have sparked as much interest and as many questions as GLP-1 agonists. Originally developed to manage blood sugar and support weight loss, these medications are currently being studied for their potential effects on sexual function. Some patients reported an increase in libido, while others experienced an unexpected […]
Are Sexual Side Effects Emerging With GLP-1 Agonists? Read More »
by Mass General Brigham edited by Sadie Harley, reviewed by Robert Egan Editors’ notes Credit: Unsplash/CC0 Public Domain In a study led by researchers at Mass General Brigham, pregnant individuals who stopped taking popular weight loss GLP-1 medications before or early in their pregnancy tended to gain more weight and have higher risks of diabetes and hypertensive disorders
Miriam E. Tucker November 11, 2025 ATLANTA — The investigational ultra long-acting injectable GLP-1 receptor agonist (RA) MET-097 produced up to 14% weight loss, with the potential for improved tolerability compared with other GLP-1 RAs and once-monthly dosing, new phase 2 data suggested. Findings from Metsera’s phase 2b VESPER-1 trial along with early VESPER-3 trial
Ultra Long-Acting GLP-1 May Offer Benefits Over Others Read More »
Marcia Frellick November 19, 2025 CHICAGO — With the soaring use of GLP-1 receptor agonists (RAs), popular terms for potential negative effects associated with treatment, such as “Ozempic face,” have been coursing through social media, feeding stigma and confusion for patients. Addressing this issue, researchers presented patient survey data on how GLP-1s affect the skin
Patient-Reported Skin Changes After GLP-1 Use Explored Read More »
By Bronwyn Thompson October 19, 2025 Facebook Twitter LinkedIn Reddit Flipboard Email Rybelsus has now been expanded to treat those at high risk of heart attack and stroke Depositphotos View 1 Images The age of the GLP-1 drug has reached yet another milestone, with the US Food and Drug Administration green-lighting Novo Nordisk’s once-daily oral semaglutide
First oral GLP-1 cuts cardiovascular risk by 14% – and it’s now FDA-approved Read More »
Microdosing has taken hold of the internet, moving from psychedelics to GLP obesity drugs. On any given day, it’s easy to encounter multiple telehealth company ads across numerous social media platforms aimed at luring people with obesity who’ve been unable to afford or acquire GLP-1 medications or tempting individuals interested in cosmetic weight loss. These companies promise
Are Your Patients Microdosing GLP-1s Without Your Knowledge? Read More »
The hype over GLP-1 drugs has become so great, some patients may be dead set on getting started on these obesity medications, no matter what you think. But as a physician, it’s your job to make sure it’s an appropriate step and that your patient is prepared for what it entails. There are ways to
How to Handle Patients Who Just Want a GLP-1 Prescription Read More »
Patent protection for semaglutide is set to expire in several major markets. For liraglutide, that has already happened. The change could make some of the most successful obesity and diabetes drugs of recent years far more affordable for millions of patients. In Europe, however, it may still take years before generics reach the market and prices fall. The shift also poses potential
Post-Patent GLP-1s: A Win for Access or a Blow to Safety? Read More »
October 06, 2025Vienna — The investigational monoclonal antibody trevogrumab was associated with lean mass preservation and greater loss of fat mass in people taking semaglutide, an interim trial data showed. Findings from Regeneron Pharmaceuticals Inc’s ongoing phase 2 COURAGE trial were presented at European Association for the Study of Diabetes (EASD) 2025 Annual Meeting by Ofri Mosenzon, MD, of the
Myostatin Blocker Preserves Muscle With GLP-1 Treatment – obesity Read More »
The potential anti-aging health benefits of GLP-1s are appealing to adults over 65. However, physicians should be aware of the age-related health issues that GLP-1 use could impact. Potential Benefits Studies of older adults using GLP-1s show improved kidney function and cardiovascular health, including better blood flow and a lower risk of stroke. Research also indicates that GLP-1s may
GLP-1s in Older Adults: Benefits and Risks to Watch Read More »
Vitae, vulputate lorem id egestas neque egestas habitant sit ante nec.
✆ Phone (appointments): 714-639-4013
Email: care@imedmg.com
Address: 615 E Chapman Ave, Suite #300, Orange, CA 92866